CI-FISH, GEP, and SNPs Correlate Genomic Categories with Risk Stratification in Children with T-ALL

被引：0
|
作者：
la Starza, Roberta
Lettieri, Antonella [1 ]
Pierini, Valentina [2 ]
Matteucci, Caterina [3 ]
Nofrini, Valeria [2 ]
Gorello, Paolo [2 ]
Songia, Simona [1 ]
Crescenzi, Barbara [2 ]
te Kronnie, Geertruy [4 ]
Giordan, Marco [5 ]
Leszl, Anna [6 ]
Valsecchi, Maria Grazia [7 ]
Aversa, Franco [8 ]
Basso, Giuseppe
Biondi, Andrea [9 ]
Conter, Valentino
Cazzaniga, Giovanni [1 ]
Mecucci, Cristina [2 ]
机构：
[1] Univ Milano Bicocca, Pediat Clin, Ctr Ric Tettamanti, Monza, Italy
[2] Univ Perugia, Hematol Unit, I-06100 Perugia, Italy
[3] Univ Perugia, Perugia, Cote Ivoire
[4] Univ Padua, Dept Pediat, SSD Ematol Clin Sperimentale, Padua, Italy
[5] Univ Padua, Dept Woman & Child Hlth, Padua, Italy
[6] Univ Padua, Lab Hematol Oncol, Padua, Italy
[7] Univ Milano Bicocca, EsPhALL Trial Data Ctr, Dept Clin & Prevent Med, Monza, Italy
[8] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy
[9] San Gerardo Hosp, Pediat Clin, Monza, Italy
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2485.2485
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2485
引用
收藏
页数：2
相关论文
共 9 条
  • [1] COMBINED INTERPHASE FLUORESCENCE IN SITU HYBRIDIZATION (CI-FISH) DELINEATES THE GENOMIC PROFILE OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN
    La Starza, R.
    Pierini, V.
    Crescenzi, B.
    Matteucci, C.
    Nofrini, V.
    Leszl, A.
    Cazzaniga, G.
    Gorello, P.
    Romoli, S.
    Lettieri, A.
    Aversa, F.
    Basso, G.
    Mecucci, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 5 - 6
  • [2] NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients
    Simonin, Mathieu
    Vasseur, Loic
    Lengline, Etienne
    Lhermitte, Ludovic
    Cabannes-Hamy, Aurelie
    Balsat, Marie
    Schmidt, Aline
    Dourthe, Marie Emilie
    Touzart, Aurore
    Graux, Carlos
    Grardel, Nathalie
    Cayuela, Jean-Michel
    Arnoux, Isabelle
    Gandemer, Virginie
    Huguet, Francoise
    Ducassou, Stephane
    Lheritier, Veronique
    Chalandon, Yves
    Ifrah, Norbert
    Dombret, Herve
    Macintyre, Elizabeth A.
    Petit, Arnaud
    Rousselot, Philippe
    Lambert, Jerome
    Baruchel, Andre
    Boissel, Nicolas
    Asnafi, Vahid
    BLOOD, 2023, 142
  • [3] NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
    Simonin, Mathieu
    Vasseur, Loic
    Lengline, Etienne
    Lhermitte, Ludovic
    Cabannes-Hamy, Aurelie
    Balsat, Marie
    Schmidt, Aline
    Dourthe, Marie-Emilie
    Touzart, Aurore
    Graux, Carlos
    Grardel, Nathalie
    Cayuela, Jean-Michel
    Arnoux, Isabelle
    Gandemer, Virginie
    Huguet, Francoise
    Ducassou, Stephane
    Lheritier, Veronique
    Chalandon, Yves
    Ifrah, Norbert
    Dombret, Herve
    Macintyre, Elizabeth
    Petit, Arnaud
    Rousselot, Philippe
    Lambert, Jerome
    Baruchel, Andre
    Boissel, Nicolas
    Asnafi, Vahid
    BLOOD, 2024, 144 (15) : 1570 - 1580
  • [4] Identification of Genomic classifiers that distinguish induction failure in T-ALL: A report from the children's oncology group
    Winter, Stuart S.
    Jiang, Zeyu
    Khawaja, Hadya M.
    Griffin, Timothy
    Devidas, Meenakshi
    Asselin, Barbara L.
    Larson, Richard S.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 606 - 606
  • [5] The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children
    Clappier, Emmanuelle
    Cuccuini, Wendy
    Kalota, Anna
    Crinquette, Antoine
    Cayuela, Jean-Michel
    Dik, Willem A.
    Langerak, Anton W.
    Montpellier, Bertrand
    Nadel, Bertrand
    Walrafen, Pierre
    Delattre, Olivier
    Aurias, Alain
    Leblanc, Thierry
    Dombret, Herve
    Gewirtz, Alan M.
    Baruchel, Andre
    Sigaux, Francois
    Soulier, Jean
    BLOOD, 2007, 110 (04) : 1251 - 1261
  • [6] The Combination of MRD and Copy Number Alterations (CNAs) Defines an Ultra-High Risk Group of Children with Primary T-Lymphoblastic Leukemia (T-ALL)
    Kunz, Joachim B.
    Seemann, Julia
    Zimmermann, Martin
    Richter-Pechanska, Paulina
    Bandapalli, Obul Reddy
    Orlova, Elena
    Cario, Gunnar
    Stanulla, Martin
    Schrappe, Martin
    Zaliova, Marketa
    Trka, Jan
    Panzer-Grumayer, Renate
    Mann, Georg
    Muckenthaler, Martina U.
    Korbel, Jan O.
    Kulozik, Andreas E.
    BLOOD, 2016, 128 (22)
  • [7] Outcome of children with T-cell acute lymphoblastic leukemia (T-ALL) and standard risk (SR) features: Results of CCG-1952, CCG-1991 and POG 9404.
    Matloub, Y
    Asselin, BL
    Stork, LC
    Devidas, M
    Sather, H
    Nachman, J
    Seibel, N
    Carroll, W
    Camitta, B
    Gaynon, PS
    BLOOD, 2004, 104 (11) : 195A - 195A
  • [8] Nelarabine in combination with intensive modified BFM AALL00P2: A pilot study for the treatment of high risk T-ALL a report from the Children's Oncology Group
    Dunsmore, K.
    Devidas, M.
    Borowitz, M. J.
    Winick, N.
    Hunger, S. P.
    Carroll, W. L.
    Camitta, B. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Risk-Adjusted Therapies Yield Equivalent Outcomes for Adolescents and Young Adults (AYAs) Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) on Children's Oncology Group (COG) Studies AALL0434 and AALL1231
    Colace, Susan I.
    Devidas, Meenakshi
    Chen, Zhiguo
    Hayashi, Robert J.
    Wood, Brent L.
    Esiashvili, Natia
    Patel, Samir
    Carroll, Andrew J.
    Heerema, Nyla A.
    Asselin, Barbara
    Rabin, Karen R.
    Zweidler-McKay, Patrick A.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Winick, Naomi J.
    Carroll, William L.
    Teachey, David T.
    Winter, Stuart S.
    Dunsmore, Kimberly P.
    BLOOD, 2023, 142
1